Pr ecis: These findings may pave the way for a metabolic classification of prostate tumors that is complementary to genomics and signaling pathway analyses, with implications for the development of metabolic diagnostics and targeted therapeutics.
MICROENVIRONMENT AND IMMUNOLOGY
Pr ecis: This study identifies specific leukocyte classes that are responsible for conferring resistance to oncolytic viral therapy in a syngeneic orthotopic model of glioma, demonstrating the importance of immunocompetency in preclinical models of this type of therapy and suggesting immune-based strategies to improve its efficacy. Pr ecis: These results illuminate a central mechanism of glioma progression and provide a rationale to target this mechanism as a novel treatment in this setting. 
ABOUT THE COVER
Myostatin gene inactivation drastically reduces the development of polyposis in Apc Min/þ mouse. The Apc Min/þ mouse has a mutation in the adenomatous polyposis coli (Apc) tumor suppressor gene, which is responsible for the development of colorectal cancer and cachexia. Myostatin is a master negative regulator of skeletal muscle mass. It was found that inactivation of the myostatin gene on the Apc Min/þ genetic background, a condition that completely prevents cancer cachexia, strikingly reduced the number and size of intestinal polyps. For details see article by Gallot and colleagues on page 7344. To request permission to re-use all or part of this article, contact the AACR Publications Department at
